248 related articles for article (PubMed ID: 22272141)
1. Genetic and epigenetic traits as biomarkers in colorectal cancer.
Berg M; Søreide K
Int J Mol Sci; 2011; 12(12):9426-39. PubMed ID: 22272141
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
Gyparaki MT; Basdra EK; Papavassiliou AG
J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
Bae JM; Cho NY; Kim TY; Kang GH
Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
[TBL] [Abstract][Full Text] [Related]
4. Driver Gene Mutations and Epigenetics in Colorectal Cancer.
Raskov H; Søby JH; Troelsen J; Bojesen RD; Gögenur I
Ann Surg; 2020 Jan; 271(1):75-85. PubMed ID: 31188207
[TBL] [Abstract][Full Text] [Related]
5. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic biomarkers in colorectal cancer: premises and prospects.
Zamani M; Hosseini SV; Mokarram P
Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.
Grady WM
Adv Cancer Res; 2021; 151():425-468. PubMed ID: 34148620
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.
Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M
Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561
[TBL] [Abstract][Full Text] [Related]
9. Genetic and molecular origins of colorectal Cancer among the Iranians: an update.
Abbaszadegan MR; Moghbeli M
Diagn Pathol; 2018 Dec; 13(1):97. PubMed ID: 30579343
[TBL] [Abstract][Full Text] [Related]
10. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
11. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.
Mayor R; Casadomé L; Azuara D; Moreno V; Clark SJ; Capellà G; Peinado MA
Br J Cancer; 2009 May; 100(10):1534-9. PubMed ID: 19384295
[TBL] [Abstract][Full Text] [Related]
12. Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer molecular biology moves into clinical practice.
Pritchard CC; Grady WM
Gut; 2011 Jan; 60(1):116-29. PubMed ID: 20921207
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
16. Advances in epigenetic biomarker research in colorectal cancer.
Wang X; Kuang YY; Hu XT
World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
[TBL] [Abstract][Full Text] [Related]
17. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
[TBL] [Abstract][Full Text] [Related]
18. Biomarker correlation network in colorectal carcinoma by tumor anatomic location.
Nishihara R; Glass K; Mima K; Hamada T; Nowak JA; Qian ZR; Kraft P; Giovannucci EL; Fuchs CS; Chan AT; Quackenbush J; Ogino S; Onnela JP
BMC Bioinformatics; 2017 Jun; 18(1):304. PubMed ID: 28623901
[TBL] [Abstract][Full Text] [Related]
19. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.
Kim JH; Kang GH
World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661
[TBL] [Abstract][Full Text] [Related]
20. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
Shima K; Morikawa T; Baba Y; Nosho K; Suzuki M; Yamauchi M; Hayashi M; Giovannucci E; Fuchs CS; Ogino S
Cancer Causes Control; 2011 Feb; 22(2):301-9. PubMed ID: 21140203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
